Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Management of menorrhagia


Published on

Management of menorrhagia according to latest guidelines. It is just summary of the latest guidelines.

Published in: Healthcare, Health & Medicine
  • Be the first to comment

Management of menorrhagia

  1. 1. Amalina Mohd Daud 0917298 Management of Menorrhagia
  2. 2. Outline  Pharmacological treatment  Surgical treatment  Lifestyle modifications
  3. 3. Pharmacological treatment Choices 1. Hormonal treatment 2. Non-hormonal treatment
  5. 5. LNG-IUS Vertical stem: release daily doses of 20 micrograms of LNG Effects: -prevent endometrial proliferation -thicken cervical mucus -suppress ovulation Cost effective when compared with other hormonal and non hormonal treatments Reduction of MBL between 71-96% -benefit seen after 6 months
  6. 6. COCP Contain estrogen and progestogen in combinations Act on HPO axis to suppress ovulation and fertility -cause withdrawal bleeding Reduces MBL by 43 % - Greater than naproxen - Lesser than danazol and tranexamic acid Less benefit with higher cost
  7. 7. Oral Progestogen Progesterone -hormone produced during luteal phase -cause secretory transformation of endometrium  bleeding when levels fall Reduction of MBL by 84% (93% : LNG) Requires long course regimen
  8. 8. Danazol Anti-estogenic and anti-progesteronic activity -antiproliferative to endometrium -anovulatory by preventing GnRH at pituitary Reduce MBL by 50% Significant androgenic side effects -weight gain -acne -hirsutism -voice changes Reversible with treatment cessation
  9. 9. GnRH-analogues Synthetic peptide that act like a natural GnRH but with longer biological half life Action 1. Flare effect -increase FSH and LH 2. Profoung hypogonadal effect - after 10 days downregulation No follicular development, estrogen production, no ovulation, no progeterone, no menses Treatment 1. Hormonal sensitive cancer -breast cancer, prostate cancer 2. Estrogen dependant lesion - leiomyoma, endometriosis Reduces MBL but with high adverse effects
  10. 10. Non-hormonal treatments
  11. 11. Tranexamic acid Competitive inhibitor of plasminogen activator -antifibrinolytic agents Menorrhagia -Reduced breakdown of fibrin preformed clot in spiral endometrium arterioles  reduce MBL Reduce MBL by 34-59% Cost effective when compared with other NSAIDS and no treatment -not when compared with LNG-IUSHowever, -not reduce dysmenorrhea -not a contraceptive -not regulate cycles Dosage: 1g ( 2 tablets) 3-4x daily from onset of bleeding up to 4 days
  12. 12. NSAIDs Reduce prostaglandin synthesis by inhibiting COX Prostaglandin: - Inflammatory response - Pain pathways - Uterine cramps - Uterine bleeds Reduces MBL 20-49% but tranexamic acid and danazol reduces MBL greater -better AE profile than danazol Less cost effective than LNG and tranexamic acid Treatment of dysmenorrhea However, - Not contraceptions - Not to be used in bleeding disorders
  13. 13. Recommendation for Pharmaceutical Approach
  14. 14. Recommendations  Considered in - no structural or histological abnormalities - fibroid <3 cm that not distort uterus  Choices depends on wish to conceive  If either can, follow order 1. LNG-IUS 2. Tranexamic acid or COCP 3. Oral Progestogen
  15. 15.  If treatment is needed during investigations or before definite treatment - tranexamic acid or NSAIDs  If coexist with dysmenorrhea  NSAIDs  Stop NSAIDs and tranexamic acid if no improvement after 3 cycles  GnRH-a -recommended prior to surgery -other treatments of uterine fibroids (UAE, surgery) is contraindicated
  16. 16.  Not to be used as HMB treatment -Danazol -Ethamsylate - Oral progestogen during luteal phase
  17. 17. Surgical treatments
  18. 18. Endometrial Ablation Indications - Severe bleeding that impact quality of life - Not want to remain fertile - Normal size uterus, small fibroids How it works? - Remove endometrial lining will stop heavy bleeding - Recurrence occur and repeated surgery can be done - Effective contraception after surgery
  19. 19. Effect on MBL - Reduce MBL and improve quality of life - Less effective than hysterectomy Unwanted outcomes -vaginal discharge - Increasing dysmenorrhea - Infection (less common)
  20. 20. Hysterectomy Indications - Heavy bleeding with failed other treatment options - Don’t want to remain fertile - Want period to stop - Or, large fibroids Adverse Outcomes - infection-common - Intraoperative hemorrhage, damage abdominal organs, urinary dysfunction - With oophorectomy menopausal like syndrome
  21. 21. Uterine artery embolization (UAE) Indications - Heavy bleeding - Large fibroids How it works? - Small particles introduced into artery supply to the uterus  fibroid shrinks Adverse outcomes - Persistent vaginal discharge - Post-embolisation syndrome: pain, nausea, vomiting and fever - Need additional surgery - Premature ovarian failure - hematoma Fertility maintained!
  22. 22. Myomectomy Indications - Heavy bleeding - Large fibroids How it works? - Fibroids are removed Adverse outcomes - Adhesion ; pain and impaired fertility - Need additional surgery - Recurrence of fibroids - Perforation (hysteroscopic route) - infection